Chapter Phar 7

Ch. Phar 7 Note Note: Chapter Phar 7 as it existed on December 31, 2020, was repealed and a new chapter Phar 7 was created, effective January 1, 2021.

subch. I of ch. Phar 7 Subchapter I — General

Phar 7.01 Phar 7.01 Definitions. In this chapter:

Phar 7.01(1) (1) “Control number” means a unique number used to identify a repackaged drug or drug product in reference to a record that contains NDC, expiration date, and lot number.

Phar 7.01(2) (2) “Managing pharmacist” means a pharmacist who accepts responsibility for the operation of a pharmacy in conformance with all laws and rules pertinent to the practice of pharmacy, and who is personally in full and actual charge of the pharmacy and personnel.

Phar 7.01(3) (3) “NDC” means national drug code.

Phar 7.01(4) (4) “Repackaging for stock” means transferring a non-sterile drug product from the stock container in which it was distributed by the original manufacturer and placing it into a different stock container as a source for subsequent prescription dispensing without further manipulation of the drug.

Phar 7.01(5) (5) “Standing order” means an order transmitted electronically or in writing by a practitioner for a drug or device that does not identify a particular patient at the time it is issued for the purpose of drug or device dispensing or administration to individuals that meet criteria of the order.

Phar 7.01 History History: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21.

Phar 7.02 Phar 7.02 Prescription.

Phar 7.02(1) (1) Requirements. A prescription drug order shall include all of the following:

Phar 7.02(1)(a) (a) Date of issue.

Phar 7.02(1)(b) (b) First and last name and address of the practitioner.

Phar 7.02(1)(c) (c) Prescriptions ordered by a delegate of the practitioner shall include the first and last name of the delegate and the first and last name and address of the practitioner.

Phar 7.02(1)(d) (d) Name, strength, and quantity of the drug product or device.

Phar 7.02(1)(e) (e) Directions for use of the drug product or device.

Phar 7.02(1)(f) (f) Refills, if any.

Phar 7.02(1)(g) (g) Symptom or purpose for which the drug is being prescribed if the patient indicates in writing to the practitioner that the patient wants the symptom or purpose for the prescription to be disclosed on the label.

Phar 7.02(1)(h) (h) Name and address of the patient except as provided in ss. 118.2925 (3), 255.07 (2), 441.18 (2) (a) 1., 448.035 (2) and 448.037 (2) (a) 1., Stats.

Phar 7.02(1)(i) (i) If prescription is issued under s. 118.2925 (3), Stats., the name and address of the school.

Phar 7.02(1)(j) (j) If prescription is issued under s. 255.07 (2), Stats., the name and address of the authorized entity or individual.

Phar 7.02(1)(k) (k) Practitioner’s written signature, or electronic or digital signature.

Phar 7.02(2) (2) Standing order.

Phar 7.02(2)(a) (a) A prescription pursuant to a standing order shall include all of the following:

Phar 7.02(2)(a)1. 1. Date of issue.

Phar 7.02(2)(a)2. 2. First and last name and address of the practitioner.

Phar 7.02(2)(a)3. 3. Prescriptions ordered by a delegate of the practitioner shall include the first and last name of the delegate and the first and last name and address of the practitioner.

Phar 7.02(2)(a)4. 4. Name, strength, and quantity of the drug product or device.

Phar 7.02(2)(a)5. 5. Directions for use of the drug product or device.

Phar 7.02(2)(a)6. 6. Refills, if any.

Phar 7.02(2)(a)7. 7. Name and address of the patient except as provided in ss. 118.2925 (3), 255.07 (2), 441.18 (2) (a)1., 448.035 (2) and 448.037 (2) (a) 1., Stats.

Phar 7.02(2)(a)8. 8. If prescription is issued under s. 118.2925 (3), Stats., the name and address of the school.

Phar 7.02(2)(a)9. 9. If prescription is issued under s. 255.07 (2), Stats., the name and address of the authorized entity or individual.

Phar 7.02(2)(a)10. 10. An indication that the prescription is pursuant to a standing order.

Phar 7.02(2)(b) (b) A copy of the standing order shall be retained under s. Phar 7.11 (1).

Phar 7.02(3) (3) electronic prescription.

Phar 7.02(3)(a) (a) Except as provided in s. 89.068 (1) (c) 4., Stats., and as otherwise prohibited by law, a practitioner may transmit a prescription order electronically only if the patient approves the transmission and the prescription order is transmitted to a pharmacy designated by the patient. Prescription orders transmitted by facsimile machine are not considered electronic prescription orders; but rather, written prescription orders.

Phar 7.02(3)(b) (b) The prescribing practitioner’s electronic signature, or other secure method of validation shall be provided electronically with a prescription order.

Phar 7.02(4) (4) Verbal prescription. Verbal prescription orders may be received at a pharmacy via a direct conversation, telephone answering device or voice mail. The verbal prescription shall be reduced to writing or entered into a computer system under s. Phar 7.11 (2) and the prescription record shall indicate the pharmacist responsible for the accuracy of the prescription information.

Phar 7.02(5) (5) Alterations. Any alterations that modify the original intent of a prescription shall be documented including the identification of the pharmacist responsible for the alteration and the practitioner or practitioner’s delegate who authorized the alteration.

Phar 7.02 History History: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (1) (j), (2) (a) 9., 10. made under s. 35.17, Stats., Register December 2020 No. 780.

Phar 7.03 Phar 7.03 Drug utilization review.

Phar 7.03(1) (1) A pharmacist shall complete a drug utilization review by reviewing the patient record prior to dispensing each prescription drug order for all of the following:

Phar 7.03(1)(a) (a) Known allergies.

Phar 7.03(1)(b) (b) Rational therapy.

Phar 7.03(1)(c) (c) Contraindications.

Phar 7.03(1)(d) (d) Reasonable dose, duration of use, and route of administration, considering the age and other patient factors.

Phar 7.03(1)(e) (e) Reasonable directions for use.

Phar 7.03(1)(f) (f) Potential or actual adverse drug reactions.

Phar 7.03(1)(g) (g) Drug interactions with food, beverages, other drugs or medical conditions.

Phar 7.03(1)(h) (h) Therapeutic duplication.

Phar 7.03(1)(i) (i) Reasonable utilization and optimum therapeutic outcomes.

Phar 7.03(1)(j) (j) Potential abuse or misuse.

Phar 7.03(2) (2) Upon recognizing a concern with any of the items in sub. (1) (a) to (j), the pharmacist shall take steps to mitigate or resolve the problem.

Phar 7.03 History History: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (1) (d) made under s. 35.17, Stats., Register December 2020 No. 780.

Phar 7.04 Phar 7.04 Transferring prescription order information.

Phar 7.04(1) (1) General requirements.

Phar 7.04(1)(a) (a) A transfer of prescription order information between pharmacies licensed in this state or another state, for the purpose of original or refill dispensing of non-controlled substances and refills of controlled substances, may occur if all of the following conditions are satisfied:

Phar 7.04(1)(a)1. 1. The transfer of prescription order information is communicated in one of the following ways:

Phar 7.04(1)(a)1.a. a. Verbal communication between two pharmacists.

Phar 7.04(1)(a)1.b. b. Electronically or by facsimile machine between the two pharmacies.

Phar 7.04(1)(a)2. 2. A transfer of prescription information verbally shall be reduced to writing or entered into a computer system under s. Phar 7.11 (2) and the prescription record shall indicate the pharmacist responsible for the accuracy of the prescription information.

Phar 7.04(1)(b) (b) A pharmacist shall transfer a prescription upon patient request pursuant to this section.

Phar 7.04(2) (2) Non-controlled substances. The transfer of prescription order information for non-controlled substances for the purposes of original or refill dispensing is permissible pursuant to the following requirements:

Phar 7.04(2)(a) (a) The prescription record of the transferred prescription shall include the following information:

Phar 7.04(2)(a)1. 1. The word “VOID” is written on the face of the invalidated prescription order or recorded in a similar manner to “VOID” on a prescription order in a computer system meeting the requirements of s. Phar 7.11 (2) (a).

Phar 7.04(2)(a)2. 2. The name and address of the pharmacy to which it was transferred, the date and the first and last name of the pharmacist transferring the information are recorded on the invalidated prescription order or in a computer system meeting the requirements s. Phar 7.11 (2) (a).

Phar 7.04(2)(b) (b) Unless a computer system meeting the requirements in sub. (4) is used, the transferred prescription order information shall include the following:

Phar 7.04(2)(b)1. 1. The word “TRANSFER” on the face of the transferred prescription order or recorded in a similar manner in a computer system.

Phar 7.04(2)(b)2. 2. The first and last name and address of the patient, the first and last name and address of the prescribing practitioner.

Phar 7.04(2)(b)3. 3. Name, strength, form and quantity of the drug product or device prescribed and the directions for use.

Phar 7.04(2)(b)4. 4. The date of issuance of the original prescription order, the original prescription order number, the original number of refills authorized on the original prescription order and the date of original dispensing if the prescription order has previously been dispensed.

Phar 7.04(2)(b)5. 5. The number of valid refills or total quantity remaining and the date of the last refill.

Phar 7.04(2)(b)6. 6. The pharmacy’s name and address from which the prescription order information was transferred.

Phar 7.04(2)(b)7. 7. The first and last name of the pharmacist transferring and receiving the prescription order information.

Phar 7.04(3) (3) Controlled substances. The transfer of original prescription information for a controlled substance listed in Schedule III – V shall meet the following requirements:

Phar 7.04(3)(a) (a) The transfer of prescription order information is permissible only on a one-time basis. Pharmacies electronically sharing a computer system meeting the requirements of sub. (4) may transfer up to the maximum refills permitted by law and the prescriber’s authorization.

Phar 7.04(3)(b) (b) Notwithstanding sub. (1) (a), the transfer shall be communicated directly between 2 licensed pharmacists.

Phar 7.04(3)(c) (c) The transferring pharmacist shall do all of the following:

Phar 7.04(3)(c)1. 1. Write the word “VOID” on the face of the invalidated prescription. For electronic prescriptions, information that the prescription has been transferred shall be added to the prescription record.

Phar 7.04(3)(c)2. 2. Record on the reverse of the invalidated prescription or in the electronic prescription record all of the following:

Phar 7.04(3)(c)2.a. a. Name, address and DEA registration number of the pharmacy to which it was transferred.

Phar 7.04(3)(c)2.b. b. The first and last name of the pharmacist receiving the prescription order.

Phar 7.04(3)(c)3. 3. Record the date of the transfer.

Phar 7.04(3)(c)4. 4. Record the first and last name of the pharmacist transferring the information.

Phar 7.04(3)(d) (d) For paper prescriptions and prescriptions received verbally and reduced to writing by the pharmacist, the pharmacist receiving the transferred prescription information shall write the word “TRANSFER” on the face of the transferred prescription and reduce to writing all information required to be on the prescription, including all of the following:

Phar 7.04(3)(d)1. 1. Date of issuance of the original prescription order.

Phar 7.04(3)(d)2. 2. Original number of refills authorized on the original prescription order.